Yung Bok Han

Title: Yung Bok Han: Innovator in Anti-Cancer Compositions

Introduction

Yung Bok Han, a prominent inventor based in Seoul, South Korea, has made significant strides in the field of medicinal chemistry. With a focus on developing innovative anti-cancer treatments, his research has led to the creation of a unique composition that combines acridine derivatives and guanosine compounds.

Latest Patents

Han holds one patent titled "Anti-cancer compositions." This invention presents a novel approach in cancer treatment by utilizing a composition containing acridine derivatives and guanosine compounds in a specific weight ratio. The preferred ratio ranges from 1:0.1-5.0, with an optimal range of 1:0.3-3.0. The most favorable combination involves acriflavine neutral and guanosine hydrate, which, when used together, demonstrate a remarkable increase in anti-cancer efficacy while reducing toxicity compared to using each component individually.

Career Highlights

Throughout his career, Yung Bok Han has worked with reputable companies, including Tae Rim Pharm. Co., Ltd. His work has established him as a key inventor in the field of pharmaceuticals, particularly in developing effective compositions for cancer treatment.

Collaborations

Yung Bok Han has collaborated with notable colleagues, including Hong Ki Kyung and Chun Won Kim. These collaborations have likely contributed to the advancement of his research and the successful development of his patent.

Conclusion

Yung Bok Han's innovative work in the area of anti-cancer compositions exemplifies the importance of collaboration and novel approaches in the fight against cancer. With his patent on the synergistic effects of acridine and guanosine compounds, Han is poised to make a lasting impact on cancer treatment and research.